Lessons from Ten Years' the Prevalence of Congenital Rubella Syndrome (CRS) in the Young Population Living in a

Samileh Noorbakhsh1, Mohammad Vafaee-Shahi2, Leila Tahernia3

  • 1Pediatric Infectious Diseases, Departement & Research center, Iran University of Medical Sciences. Tehran, Iran.

Insights

Despite rubella vaccination in Iran, congenital rubella syndrome (CRS) cases persist. Continued surveillance and vaccination campaigns are crucial to prevent rubella infection and its severe consequences.

Area of Science:

  • Immunology
  • Public Health
  • Pediatrics

Background:

  • A safe and effective rubella vaccine is available and widely used in Iran.
  • Rubella vaccination campaigns have been implemented to control the spread of the virus.

Purpose of the Study:

  • To survey congenital rubella syndrome (CRS) cases one decade after the MR vaccination campaign in Iran.
  • To assess the continued incidence and impact of rubella infection despite vaccination efforts.

Main Methods:

  • A multi-stage prospective/cross-sectional study conducted in three educational hospitals in Tehran.
  • Evaluation of 186 infants and comparison of 163 blood samples from infants with suspected intrauterine infection against healthy controls.
  • Rubella immunity (IgG & IgM) in cord blood assessed using the Eliza method.

Main Results:

  • Despite the MR vaccination campaign, 5.6% of suspected cases were confirmed as CRS.
  • An additional 31 cases were classified as "compatible CRS," highlighting ongoing rubella transmission.
  • The study identified persistent fetal infection, underscoring the need for continued vigilance.

Conclusions:

  • Congenital rubella syndrome remains a concern in Iran even after a decade of vaccination.
  • Active CRS surveillance is essential to detect milder infections and prevent long-term health issues like hearing loss and developmental delays.
  • Recommendations include mass vaccination for women and girls, pre-pregnancy rubella immunity testing, and mandatory vaccination before marriage/pregnancy to eradicate CRS.
Abstract

Related Concept Videos

Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
915
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.0K
Probability Laws01:49

Probability Laws

Overview
42.2K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
769
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.5K
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
489